BioCentury
ARTICLE | Company News

Catalytica, Rhone-Poulenc Rorer deal

October 11, 1999 7:00 AM UTC

CTAL's Catalytica Pharmaceuticals Inc. subsidiary will non-exclusively manufacture RPR's worldwide supply of Synercid injectable streptogramin antibiotic to treat certain serious bacterial infections. The product received FDA approval last month. ...